United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 27, 2026 · Filed Aug 28, 2026

On Aug 27, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$522.57 for US$4.96M under a trading plan, leaving 324,443 shares. Filed Aug 28, 2026 (Form 4).

Sold
9,500 shares
Price
US$522.57 average (US$511.58 to US$531.12)
Value
US$4.96M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 27, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 27, 2026Common StockSale494US$511.58333,449Indirect
Aug 27, 2026Common StockSale642US$512.47332,807Indirect
Aug 27, 2026Common StockSale704US$513.40332,103Indirect
Aug 27, 2026Common StockSale120US$514.32331,983Indirect
Aug 27, 2026Common StockSale240US$515.33331,743Indirect
Aug 27, 2026Common StockSale280US$517.07331,463Indirect
Aug 27, 2026Common StockSale200US$518.89331,263Indirect
Aug 27, 2026Common StockSale1,003US$520.23330,260Indirect
Aug 27, 2026Common StockSale477US$521.24329,783Indirect
Aug 27, 2026Common StockSale280US$522.40329,503Indirect
Aug 27, 2026Common StockSale240US$523.60329,263Indirect
Aug 27, 2026Common StockSale744US$524.61328,519Indirect
Aug 27, 2026Common StockSale376US$525.62328,143Indirect
Aug 27, 2026Common StockSale280US$526.37327,863Indirect
Aug 27, 2026Common StockSale1,237US$528.29326,626Indirect
Aug 27, 2026Common StockSale1,308US$529.15325,318Indirect
Aug 27, 2026Common StockSale755US$530.08324,563Indirect
Aug 27, 2026Common StockSale120US$531.12324,443Indirect

Source

View original at SEC

Related